Pandemic Driven (Real-World) Data Shifts

Monday, April 24, 2023

11:30 AM – 1:15 PM GMT

Moderator(s)

Helga Gardarsdottir, PharmD, PhD,

Associate professor
Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
Utrecht, Netherlands
Tobias Gerhard, PhD, FISPE (he/him/his)

Professor and Director
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
New Brunswick, New Jersey, United States

Speaker(s)

Anne M. Butler, PhD, MS (she/her/hers)

Assistant Professor
Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
Saint Louis, MO, United States
Michael Andrew Webster-Clark, PharmD, PhD

Post-doctoral Researcher
McGill University, Department of Epidemiology, Biostatistics, and Occupational Health
McGill University
Montreal, Canada
Morten Andersen, MD, PhD

Professor
Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen
University of Copenhagen
Copenhagen, Hovedstaden, Denmark

Disclosure(s):

Helga Gardarsdottir, Dr.: No financial relationships to disclose

Tobias Gerhard, PhD, FISPE: No financial relationships to disclose

Anne Mobley Butler, PhD: No relevant disclosure to display

Michael Andrew Webster-Clark, PharmD, PhD: No relevant disclosure to display

Morten Andersen, MD, PhD: No relevant disclosure to display

The pandemic has impacted our lives in various ways during the past years. The impact on healthcare can be traced through the health care data that was generated during this time. In this session we will showcase what this means for us as pharmacoepidemiologists and our future studies that rely on use of health care data.

11:30-12:00: Impact of COVID-19 pandemic on health care seeking behaviour, real-world data capture, and nonrandomized real-world evidence studies
Anne Mobley Butler, Assistant Professor, Washington University in St. Louis, USA

12:00-12:30: Ways COVID-19 may impact unrelated pharmacoepidemiologic research
Michael Webster-Clark, post-doctoral fellow, McGill University, Canada

12:30-13:00: The changing landscape of Nordic pharmacoepidemiology during the COVID-19 ‎pandemic and prospects for the post-pandemic period
Morten Andersen, professor, Copenhagen University, Denmark ‎

13:00-13:15: Discussion